Gary W. Herschman and Kevin J. Ryan, Members of the Firm in the Health Care and Life Sciences practice, in the firm’s Newark and Chicago offices, were quoted in a Bloomberg BNA Health Law Reporter special report titled “Health-Care Transactions Update: April,” by Mary Anne Pazanowski.
Following is an excerpt (see below to download the full report in PDF format):
Gary W. Herschman, a member of Epstein, Becker & Green PC, who practices in the firm’s Newark, N.J., and New York offices, agreed that the lower numbers in April weren’t significant. The number of deals still was well within the average range for this time of year, he said. Herschman is a member of the Bloomberg BNA Health Law Reporter advisory board. …
Herschman told Bloomberg BNA that deals in the HIT sector “are all about finding efficiencies in care delivery.” Investors are attracted to technology that improves patient care, engagement and satisfaction. …
Kevin J. Ryan, of Epstein, Becker & Green PC’s Chicago office, said many HIT deals involve “very niche products—that is, very specific products for targeted markets.” Examples, he said, include deals involving software designed to track products and organizations eligible to participate in the federal government’s 340B drug pricing program.
These products, Ryan said, are trying to address programs that are difficult to administer. As a result, they are very narrowly focused.